Chat with us, powered by LiveChat Response to Crystal lopez | acewriters

******* please respond to the discussion below add citations and references 🙂 ***** In the medical world today, there are more diabetics than ever before in medical history. A problem that many diabetics face is controlling their glucose level on a day-to-day basis. A study, that was done in the United Kingdom (UK), wanted to see why this was happening. According to the study, many people first go to their general or primary care doctor for their diabetes. Only some doctors refer the patients to an endocrinologist, and that is normally only if they cannot help control the diabetes in the patient anymore (Sterzi, Auziere, Glah, & Jensen, 2016). According to the study, only 20% of patients that were included in the test, were sent to an endocrinologist, so the doctors did not want to refer their patients, but also did not know how to continue with the appropriate patient care (Sterzi et al., 2016). The way participants were selected for this study was through a panel. The doctors were then chosen based on how long they had been a doctor, their role in diabetes care, time they have been in family practice, the amount of diabetic patients they have seen in a months’ time span, and finally, how many patients they have that receive insulin injections (Sterzi et al., 2016). The type of sampling seen above, seems to be purposive sampling, because the researchers knew exactly who they wanted to study. According to one article, purposive sampling, “this is used when a diverse sample is necessary or the opinion of experts in a particular field is the topic of interest” (MartĂ­nez-Mesa, González-Chica, Duquia, Bonamigo, & Bastos, 2016). References:MartĂ­nez-Mesa, J., González-Chica, D. A., Duquia, R. P., Bonamigo, R. R., & Bastos, J. L. (2016). Sampling: how to select participants in my research study? Anais Brasileiros de Dermatologia, 91(3), 326-330. doi:10.1590/abd1806-4841.20165254 Sterzi, D., Auziere, S., Glah, D., & Jensen, M. M. (2017). Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom. Primary Care Diabetes, (3), 241.…Permalink:…

error: Content is protected !!